Landscapes / Companies
Hrain Biotechnology Co., Ltd. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
2
in active trials · 5 in all
Trials
2 active
8 since 2021
Drugs2
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 2 | — | |||
| Also tested for | Multiple Myeloma | ||||
| Open drug page | |||||
— |
Phase 1 | Jun 2029Phase 1 trial completes | |||
| Next date | Jun 2029 · Phase 1 trial completes | ||||
| Also tested for | Renal Cell Carcinoma (RCC) | ||||
| Open drug page | |||||
About
- No active trial
- anti-CD19/BCMA CAR-T cells, Human CD19-CD22 Targeted T Cells, Human CD19Targeted T Cells
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021